Study S000688

Arterial Stiffness and Endothelial Function Indexes, Relationships With Clinical and Laboratory Variables in a Group of Diabetic Patients in Treatment With Dulaglutide: a Case-control Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT03824002
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: COMPLETED
Enrollment: 92
Start: 2017-04-01
Primary completion: 2017-10-01
Lead sponsor: University of Palermo
Conditions: Diabetes Mellitus
Interventions: DRUG:Dulaglutide; DRUG:Aspart insulin; DRUG:Glargine; DRUG:Metformin; DRUG:Repaglinide
Results posted: FALSE

Registered primary outcomes

Change from Baseline Reactive Hyperemia Index at 3 and 9 months [0 months, 3 months and 9 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0010237	Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. Natale P, The Cochrane database of systematic reviews	2025	Systematic review	PMID 39963952 DOI	cites ClinicalTrials.gov:NCT03824002; registry reference DERIVED:39963952